Medical Affairs Director - Movement Disorders
Lundbeck
Summary
The Medical Affairs Director - Movement Disorders will provide strategic medical leadership for Multiple System Atrophy (MSA), supporting launch readiness and execution across the U.S. Medical Affairs organization. This role will shape and advance the U.S. medical strategy by integrating scientific evidence, external stakeholder insights, cross-functional partnership, and high-quality medical execution to address the needs of patients, caregivers, healthcare professionals, payers, and policymakers.
Job description
Key Responsibilities
Strategic Cross-Functional Partnership & Launch Readiness
- Provide expert medical perspective to co-create launch strategy together with Commercial, Patient advocacy, Market Access, Regulatory, Clinical Development, Pharmacovigilance, and other internal stakeholders.
- Partner cross-functionally to support launch readiness, lifecycle planning, and integrated evidence generation strategies.
- Translate clinical data and scientific insights into actionable strategies that inform stakeholder engagement and brand planning.
External Engagement & Scientific Leadership
- Build and maintain strong, trusted relationships with investigators, key opinion leaders (KOLs), advocacy leaders, and healthcare professionals.
- Represent US Medical Affairs in scientific forums and stakeholder engagements to reinforce Lundbeck's leadership in Multiple System Atrophy.
- Monitor evolving disease area trends, competitor activities, and policy landscape to proactively inform US and global strategies.
Medical and Scientific Communications
- Develop and execute an integrated US medical communications strategy aligned to overarching brand and development objectives, with measurable impact.
- Co-create with Global Medical Affairs to ensure US insights inform the scientific narrative, clinical value story, lexicon, data story, key messages, evidence summaries, and communication themes.
- Ensure consistent, accurate, and balanced communication of clinical data across materials.
- Own US-specific publication strategy and priorities; ensure alignment and integration with global publication plans.
- Own US congress planning and execution, including data rollout planning, abstract submission, poster and oral presentation development, symposium content, medical booth content, and pre- and post-congress communication activities.
- Develop stakeholder mapping & engagement planning.
- Oversee development of all US medical materials, medical slide decks, FAQs, scientific response documents, congress assets, field medical materials, training content, data visualizations, digital scientific content, and other non-promotional medical resources ensuring scientific accuracy, regulatory compliance, and strategic alignment.
- Partner with Field Medical to support scientific readiness, training, and consistent, compliant communication of the MSA scientific narrative.
- Serve as medical reviewer within the promotional review process, upholding the highest standards of scientific integrity and compliance.
- Manage medical writing agencies, publication vendors, freelancers, congress support vendors, budgets, timelines, and deliverables.
Requirements
- Accredited advanced scientific or clinical degree (MD, PharmD, PhD or MS)
- 5+ years of progressive, non-field-based Medical Affairs experience within pharmaceutical or biotech industry or at an agency that supports the pharmaceutical or biotech industry
- Minimum 2+ years contributing to medical strategy development, launch readiness, scientific communications, publication planning, and congress management
- Demonstrated experience designing and executing Medical Education programs (CME and non-CME)
- Strong understanding of clinical trial data, evidence generation, publication practices, and therapeutic-area strategy and translate insights into strategic recommendations
- Experience developing publication plans, congress materials, scientific platforms, and medical content
- Knowledge of compliance requirements, publication ethics, and medical/legal/regulatory review processes
- Experience serving as a medical reviewer for promotional materials, ensuring compliance and scientific rigor
- Strong analytical thinking, problem-solving capability, and data-driven decision-making skills
- Demonstrated success building collaborative cross-functional relationships and influencing without authority
- Experience managing multiple priorities in a dynamic environment
- Exceptional communication skills with ability to convey complex scientific information clearly and persuasively
- Demonstrated integrity, professionalism, and commitment to ethical standards
- Authentic, long-term engagement within the rare disease community, viewed as a trusted and mission-driven partner
- Demonstrated ability to collaborate respectfully and effectively with patient advocacy groups (PAGs), patients, caregivers, clinicians, and industry stakeholders
- Deep understanding of rare disease best practices, access and policy considerations, media engagement, and patient support ecosystems
- Strong external network across rare disease leaders, clinical societies, and alliances (e.g., Rare Disease Caucus, PFDD Consortium, FDA Rare Disease Center of Excellence)
- Highly proactive and adaptable leader capable of operating effectively in evolving, data-limited environments
- Willingness/ability to travel up to 35% domestically
Benefits
- Flexible PTO
- Medical, Dental & Vision
- 401(k) Matching
- Long-term incentive plan
- 25% bonus target
Company overview
Lundbeck is a global pharmaceutical company specializing exclusively in brain diseases, with over 70 years of neuroscience expertise. Founded in 1915 in Copenhagen, Denmark, the company has established itself as one of the world's leading innovators in treatments for central nervous system disorders. Lundbeck focuses on developing and commercializing therapies for conditions including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, and migraine. With approximately 5,000+ employees worldwide and operations in more than 50 countries, the company maintains production facilities in Denmark, France, and Italy, with research centers in Denmark and the United States. Lundbeck's portfolio includes some of the world's most widely prescribed therapies for brain diseases, reaching over 7 million people daily. The company is publicly traded on Nasdaq Copenhagen, with the Lundbeck Foundation holding approximately 70% ownership. Lundbeck's commitment to neuroscience research and patient-centered innovation has positioned it as a key player in addressing the complex challenges of brain health globally.